A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplant-Ineligible Primary Central Nervous System Lymphoma
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
European Organisation for Research and Treatment of Cancer - EORTC
European Organisation for Research and Treatment of Cancer - EORTC
European Organisation for Research and Treatment of Cancer - EORTC
International Extranodal Lymphoma Study Group (IELSG)
University College, London
Memorial Sloan Kettering Cancer Center
Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea
Memorial Sloan Kettering Cancer Center
Radiation Therapy Oncology Group
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
AIDS Malignancy Consortium
The Lymphoma Academic Research Organisation
Alliance for Clinical Trials in Oncology
M.D. Anderson Cancer Center
University of Cologne
Martin-Luther-Universität Halle-Wittenberg
Martin-Luther-Universität Halle-Wittenberg
University of Cologne
OHSU Knight Cancer Institute
Memorial Sloan Kettering Cancer Center
Newcastle-upon-Tyne Hospitals NHS Trust
Memorial Sloan Kettering Cancer Center
Ospedale Santa Croce-Carle Cuneo
Fondazione Michelangelo
University College, London
St. Louis University
Children's Oncology Group
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Northwestern University
Case Comprehensive Cancer Center
Case Comprehensive Cancer Center
Case Comprehensive Cancer Center
Case Comprehensive Cancer Center
University Hospital Freiburg